Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance
Background:Active surveillance (AS) is commonly based on standard 10-12-core prostate biopsies, which misclassify ~50% of cases compared with radical prostatectomy. We assessed the value of multiparametric magnetic resonance imaging (mpMRI)-targeted transperineal fusion-biopsies in men under AS.Meth...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
17 May 2016
|
| In: |
Prostate cancer and prostatic diseases
Year: 2016, Jahrgang: 19, Heft: 3, Pages: 283-291 |
| ISSN: | 1476-5608 |
| DOI: | 10.1038/pcan.2016.16 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1038/pcan.2016.16 Verlag, Volltext: https://www.nature.com/articles/pcan201616 
|
| Verfasserangaben: | J.P. Radtke, T.H. Kuru, D. Bonekamp, M.T. Freitag, M.B. Wolf, C.D. Alt, G. Hatiboglu, S. Boxler, S. Pahernik, W. Roth, M.C. Roethke, H.P. Schlemmer, M. Hohenfellner, B.A. Hadaschik |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1570048282 | ||
| 003 | DE-627 | ||
| 005 | 20230428184757.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180221s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/pcan.2016.16 |2 doi | |
| 035 | |a (DE-627)1570048282 | ||
| 035 | |a (DE-576)500048282 | ||
| 035 | |a (DE-599)BSZ500048282 | ||
| 035 | |a (OCoLC)1340987493 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Radtke, Jan Philipp |d 1985- |e VerfasserIn |0 (DE-588)1020328290 |0 (DE-627)688118089 |0 (DE-576)360178170 |4 aut | |
| 245 | 1 | 0 | |a Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance |c J.P. Radtke, T.H. Kuru, D. Bonekamp, M.T. Freitag, M.B. Wolf, C.D. Alt, G. Hatiboglu, S. Boxler, S. Pahernik, W. Roth, M.C. Roethke, H.P. Schlemmer, M. Hohenfellner, B.A. Hadaschik |
| 264 | 1 | |c 17 May 2016 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.02.2018 | ||
| 520 | |a Background:Active surveillance (AS) is commonly based on standard 10-12-core prostate biopsies, which misclassify ~50% of cases compared with radical prostatectomy. We assessed the value of multiparametric magnetic resonance imaging (mpMRI)-targeted transperineal fusion-biopsies in men under AS.Methods:In all, 149 low-risk prostate cancer (PC) patients were included in AS between 2010 and 2015. Forty-five patients were initially diagnosed by combined 24-core systematic transperineal saturation biopsy (SB) and MRI/transurethral ultrasound (TRUS)-fusion targeted lesion biopsy (TB). A total of 104 patients first underwent 12-core TRUS-biopsy. All patients were followed-up by combined SB and TB for restratification after 1 and 2 years. All mpMRI examinations were analyzed using PIRADS. AS was performed according to PRIAS-criteria and a NIH-nomogram for AS-disqualification was investigated. AS-disqualification rates for men initially diagnosed by standard or fusion biopsy were compared using Kaplan-Meier estimates and log-rank tests. Differences in detection rates of the SB and TB components were evaluated with a paired-sample analysis. Regression analyses were performed to predict AS-disqualification.Results:A total of, 48.1% of patients diagnosed by 12-core TRUS-biopsy were disqualified from AS based on the MRI/TRUS-fusion biopsy results. In the initial fusion-biopsy cohort, upgrading occurred significantly less frequently during 2-year follow-up (20%, P<0.001). TBs alone were significantly superior compared with SBs alone to detect Gleason-score-upgrading. NPV for Gleason-upgrading was 93.5% for PIRADS⩽2. PSA level, PSA density, NIH-nomogram, initial PIRADS score (P<0.001 each) and PIRADS-progression on consecutive MRI (P=0.007) were significant predictors of AS-disqualification.Conclusions:Standard TRUS-biopsies lead to significant underestimation of PC under AS. MRI/TRUS-fusion biopsies, and especially the TB component allow more reliable risk classification, leading to a significantly decreased chance of subsequent AS-disqualification. Cancer detection with mpMRI alone is not yet sensitive enough to omit SB on follow-up after initial 12-core TRUS-biopsy. After MRI/TRUS-fusion biopsy confirmed AS, it may be appropriate to biopsy only those men with suspected progression on MRI. | ||
| 700 | 1 | |a Kuru, Timur Hasan |d 1983- |e VerfasserIn |0 (DE-588)140427341 |0 (DE-627)618386300 |0 (DE-576)318068907 |4 aut | |
| 700 | 1 | |a Bonekamp, David |d 1977- |e VerfasserIn |0 (DE-588)128868104 |0 (DE-627)383668581 |0 (DE-576)297371797 |4 aut | |
| 700 | 1 | |a Alt, Céline D. |d 1979- |e VerfasserIn |0 (DE-588)131907492 |0 (DE-627)516071300 |0 (DE-576)298828480 |4 aut | |
| 700 | 1 | |a Hatiboglu, Gencay |d 1979- |e VerfasserIn |0 (DE-588)132495139 |0 (DE-627)522966845 |0 (DE-576)299182673 |4 aut | |
| 700 | 1 | |a Boxler, Silvan |e VerfasserIn |0 (DE-588)1109904711 |0 (DE-627)864489439 |0 (DE-576)475647440 |4 aut | |
| 700 | 1 | |a Pahernik, Sascha |d 1968- |e VerfasserIn |0 (DE-588)122063163 |0 (DE-627)081713495 |0 (DE-576)293073147 |4 aut | |
| 700 | 1 | |a Roth, Wilfried |d 1970- |e VerfasserIn |0 (DE-588)120891557 |0 (DE-627)080951279 |0 (DE-576)292433484 |4 aut | |
| 700 | 1 | |a Schlemmer, Heinz-Peter |d 1961- |e VerfasserIn |0 (DE-588)1025559967 |0 (DE-627)722927142 |0 (DE-576)17334805X |4 aut | |
| 700 | 1 | |a Hohenfellner, Markus |d 1958- |e VerfasserIn |0 (DE-588)133862518 |0 (DE-627)557857988 |0 (DE-576)300155263 |4 aut | |
| 700 | 1 | |a Hadaschik, Boris |d 1974- |e VerfasserIn |0 (DE-588)124300553 |0 (DE-627)085770930 |0 (DE-576)294109013 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Prostate cancer and prostatic diseases |d Basingstoke : Stockton Press, 1997 |g 19(2016), 3, Seite 283-291 |h Online-Ressource |w (DE-627)32047383X |w (DE-600)2008886-3 |w (DE-576)252074440 |x 1476-5608 |7 nnas |a Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance |
| 773 | 1 | 8 | |g volume:19 |g year:2016 |g number:3 |g pages:283-291 |g extent:9 |a Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/pcan.2016.16 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/pcan201616 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180221 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 124300553 |a Hadaschik, Boris |m 124300553:Hadaschik, Boris |d 910000 |d 910200 |e 910000PH124300553 |e 910200PH124300553 |k 0/910000/ |k 1/910000/910200/ |p 14 |y j | ||
| 998 | |g 133862518 |a Hohenfellner, Markus |m 133862518:Hohenfellner, Markus |d 910000 |d 910200 |e 910000PH133862518 |e 910200PH133862518 |k 0/910000/ |k 1/910000/910200/ |p 13 | ||
| 998 | |g 1025559967 |a Schlemmer, Heinz-Peter |m 1025559967:Schlemmer, Heinz-Peter |d 50000 |e 50000PS1025559967 |k 0/50000/ |p 12 | ||
| 998 | |g 120891557 |a Roth, Wilfried |m 120891557:Roth, Wilfried |p 10 | ||
| 998 | |g 122063163 |a Pahernik, Sascha |m 122063163:Pahernik, Sascha |d 50000 |e 50000PP122063163 |k 0/50000/ |p 9 | ||
| 998 | |g 1109904711 |a Boxler, Silvan |m 1109904711:Boxler, Silvan |d 910000 |d 910200 |e 910000PB1109904711 |e 910200PB1109904711 |k 0/910000/ |k 1/910000/910200/ |p 8 | ||
| 998 | |g 132495139 |a Hatiboglu, Gencay |m 132495139:Hatiboglu, Gencay |d 910000 |d 910200 |e 910000PH132495139 |e 910200PH132495139 |k 0/910000/ |k 1/910000/910200/ |p 7 | ||
| 998 | |g 128868104 |a Bonekamp, David |m 128868104:Bonekamp, David |d 50000 |e 50000PB128868104 |k 0/50000/ |p 3 | ||
| 998 | |g 140427341 |a Kuru, Timur Hasan |m 140427341:Kuru, Timur Hasan |p 2 | ||
| 998 | |g 1020328290 |a Radtke, Jan Philipp |m 1020328290:Radtke, Jan Philipp |d 910000 |d 910200 |e 910000PR1020328290 |e 910200PR1020328290 |k 0/910000/ |k 1/910000/910200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1570048282 |e 3000232044 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"language":["eng"],"recId":"32047383X","disp":"Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillanceProstate cancer and prostatic diseases","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1997/98 -"],"title":[{"title":"Prostate cancer and prostatic diseases","title_sort":"Prostate cancer and prostatic diseases"}],"origin":[{"publisher":"Stockton Press","dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisherPlace":"Basingstoke"}],"note":["Gesehen am 15.03.04"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"19(2016), 3, Seite 283-291","volume":"19","pages":"283-291","year":"2016","issue":"3","extent":"9"},"id":{"eki":["32047383X"],"issn":["1476-5608"],"zdb":["2008886-3"]}}],"note":["Gesehen am 21.02.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1038/pcan.2016.16"],"eki":["1570048282"]},"physDesc":[{"extent":"9 S."}],"language":["eng"],"title":[{"title":"Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance","title_sort":"Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance"}],"recId":"1570048282","name":{"displayForm":["J.P. Radtke, T.H. Kuru, D. Bonekamp, M.T. Freitag, M.B. Wolf, C.D. Alt, G. Hatiboglu, S. Boxler, S. Pahernik, W. Roth, M.C. Roethke, H.P. Schlemmer, M. Hohenfellner, B.A. Hadaschik"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"17 May 2016"}],"person":[{"role":"aut","given":"Jan Philipp","display":"Radtke, Jan Philipp","family":"Radtke"},{"display":"Kuru, Timur Hasan","given":"Timur Hasan","family":"Kuru","role":"aut"},{"display":"Bonekamp, David","given":"David","family":"Bonekamp","role":"aut"},{"role":"aut","display":"Alt, Céline D.","given":"Céline D.","family":"Alt"},{"role":"aut","family":"Hatiboglu","display":"Hatiboglu, Gencay","given":"Gencay"},{"role":"aut","family":"Boxler","display":"Boxler, Silvan","given":"Silvan"},{"display":"Pahernik, Sascha","given":"Sascha","family":"Pahernik","role":"aut"},{"display":"Roth, Wilfried","given":"Wilfried","family":"Roth","role":"aut"},{"role":"aut","family":"Schlemmer","display":"Schlemmer, Heinz-Peter","given":"Heinz-Peter"},{"role":"aut","family":"Hohenfellner","display":"Hohenfellner, Markus","given":"Markus"},{"given":"Boris","display":"Hadaschik, Boris","family":"Hadaschik","role":"aut"}]} | ||
| SRT | |a RADTKEJANPFURTHERRED1720 | ||